Should Prophylactic Anticoagulation Be Considered with Large Uterine Leiomyoma? A Case Series and Literature Review

Autor: Carmen Paredes Saenz, J Hebert, Mohamed A. Satti, R Raju, Frederico G. Rocha, Sierra Cuthpert, Sina Abhari, Abed Kanzy
Jazyk: angličtina
Rok vydání: 2016
Předmět:
Zdroj: Case Reports in Obstetrics and Gynecology, Vol 2016 (2016)
Case Reports in Obstetrics and Gynecology
ISSN: 2090-6692
2090-6684
Popis: Introduction. Uterine leiomyomas, also called uterine fibroids or myomas, are the most common pelvic tumors in women. They are very rarely the cause of acute complications. However, when complications occur they cause significant morbidity and mortality. Thromboembolic disease has been described as a rare complication of uterine leiomyomas. DVT is a serious illness, sometimes causing death due to acute PE.Cases. We report a case series of 3 patients with thromboembolic disease associated with uterine leiomyoma at Hurley Medical Center, Flint, Michigan, during 2015 and conduct a literature review on the topic. A literature search was conducted using Medline, PubMed, and PMC databases from 1966 to 2015.Conclusion. The uterine leiomyoma is a very rare cause of PE and only few cases have been reported. DVT secondary to uterine leiomyoma should be considered in a female presenting with abdominal mass and pelvic pressure, if there is no clear common cause for her symptoms. Thromboembolic disease secondary to large uterine leiomyoma should be treated with acute stabilization and then hysterectomy. Prophylactic anticoagulation would be beneficial for lowering the risk of VTE in patients with large uterine leiomyoma.
Databáze: OpenAIRE
Externí odkaz: